 |
Second Annual Meeting, Hepatotoxicity Steering Group Meeting,
January, 2003, Rockville, MD
Presentations
Mark Avigan, M.D., FDA
Issues Surrounding
Identification of Drug-Induced Liver Injury [PPT]
Jose Serrano, M.D, Ph.D.,
National Institute of Diabetes and Digestive and Kidney
Diseases
NIDDK Hepatotoxicity
Network [PPT]
Edwin J. Matthews, Ph.D., FDA
MCASE Prediction
of Hepatotoxicity using Post-Market Adverse Effects Data [PPT]
Paul B. Watkins, University of
North Carolina, Chapel Hill, N.C.
Identifying
susceptible persons with markers [PPT]
 Back
to Top 
Back to Liver Toxicity
Date created: June 3, 2005 |
|
